Back
Knight Therapeutics Vs. Restart Life Sciences Industry Stock Comparison
Sell
16
GUD.TO
Knight Therapeutics
Last Price:
5.28
Seasonality Move:
0.47%
Sell
22
HEAL.X.CX
Restart Life Sciences
Last Price:
0.02
Seasonality Move:
16.67%
Sell
16
Knight Therapeutics (GUD.TO)
is a Sell
Is Knight Therapeutics a Buy, Sell or Hold?
- The current Knight Therapeutics [GUD.TO] share price is $5.28. The Score for GUD.TO is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- GUD.TO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Restart Life Sciences (HEAL.X.CX)
is a Sell
Is Restart Life Sciences a Buy, Sell or Hold?
- The current Restart Life Sciences [HEAL.X.CX] share price is $0.02. The Score for HEAL.X.CX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- HEAL.X.CX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GUD.TO Stock Price Chart
What is Knight Therapeutics's stock price today?
-
The Knight Therapeutics share price today is $5.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GUD.TO is experiencing slight selling pressure.
HEAL.X.CX Stock Price Chart
What is Restart Life Sciences's stock price today?
-
The Restart Life Sciences share price today is $0.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HEAL.X.CX is experiencing slight buying pressure.
GUD.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 44.63 | Sell |
| Chaikin Money Flow: | -9807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.18 - 5.34) | Buy |
| Bollinger Bands (100): | (5.36 - 5.88) | Sell |
HEAL.X.CX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 36.01 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.02 - 0.04) | Sell |
| Bollinger Bands (100): | (0.02 - 0.06) | Sell |
GUD.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.34 | Sell |
| 20-day SMA: | 5.29 | Sell |
| 50-day SMA: | 5.48 | Sell |
| 200-day SMA: | 5.65 | Sell |
| 8-day EMA: | 5.32 | Sell |
| 20-day EMA: | 5.33 | Sell |
| 50-day EMA: | 5.45 | Sell |
| 200-day EMA: | 5.54 | Sell |
HEAL.X.CX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.02 | Sell |
| 20-day SMA: | 0.03 | Sell |
| 50-day SMA: | 0.03 | Sell |
| 200-day SMA: | 0.06 | Sell |
| 8-day EMA: | 0.02 | Sell |
| 20-day EMA: | 0.03 | Sell |
| 50-day EMA: | 0.03 | Sell |
| 200-day EMA: | 0.06 | Sell |
Knight Therapeutics Earnings Growth & GUD.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.10 per share.
Restart Life Sciences Earnings Growth & HEAL.X.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Knight Therapeutics Technical Analysis
| Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Restart Life Sciences Technical Analysis
| Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||